Evidence map›Paper›PMID 24571349›Full record

ArticleACS nano2014

Immunochromatographic diagnostic test analysis using Google Glass.

Steve Feng, Romain Caire, Bingen Cortazar, Mehmet Turan, Andrew Wong, Aydogan Ozcan

Abstract read
In one paragraph

Article in ACS nano, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 171 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Human-Device Interaction in the Life Science Laboratory.Advances in biochemical engineering/biotechnology · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Microfluidic Point-of-Care Testing: Commercial Landscape and Future Directions.Frontiers in bioengineering and biotechnology · 2020
    Review
  11. Developing Gold Nanoparticles-Conjugated Aflatoxin B1 Antifungal Strips.International journal of molecular sciences · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Steve FengElectrical Engineering Department, ‡Bioengineering Department, §California NanoSystems Institute, and ⊥Department of Surgery, David Geffen School of Medicine, University of California , Los Angeles, California 90095, United States.
Romain Caire
Bingen Cortazar
Mehmet Turan
Andrew Wong
Aydogan Ozcan
California NanoSystems Institute · USUniversity of California, Los Angeles · US

Funding

Towards Mega-Throughput, Label-free Genomics and Proteomics: Revolutionizing MicrDP2OD006427 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI OZCAN, AYDOGAN · 2009 to 2009
$2.3M
NIH HHS DP2 OD006427NIH HHS DP2OD006427
6 · The paper itself

Abstract

We demonstrate a Google Glass-based rapid diagnostic test (RDT) reader platform capable of qualitative and quantitative measurements of various lateral flow immunochromatographic assays and similar biomedical diagnostics tests. Using a custom-written Glass application and without any external hardware attachments, one or more RDTs labeled with Quick Response (QR) code identifiers are simultaneously imaged using the built-in camera of the Google Glass that is based on a hands-free and voice-controlled interface and digitally transmitted to a server for digital processing. The acquired JPEG images are automatically processed to locate all the RDTs and, for each RDT, to produce a quantitative diagnostic result, which is returned to the Google Glass (i.e., the user) and also stored on a central server along with the RDT image, QR code, and other related information (e.g., demographic data). The same server also provides a dynamic spatiotemporal map and real-time statistics for uploaded RDT results accessible through Internet browsers. We tested this Google Glass-based diagnostic platform using qualitative (i.e., yes/no) human immunodeficiency virus (HIV) and quantitative prostate-specific antigen (PSA) tests. For the quantitative RDTs, we measured activated tests at various concentrations ranging from 0 to 200 ng/mL for free and total PSA. This wearable RDT reader platform running on Google Glass combines a hands-free sensing and image capture interface with powerful servers running our custom image processing codes, and it can be quite useful for real-time spatiotemporal tracking of various diseases and personal medical conditions, providing a valuable tool for epidemiology and mobile health.

Indexed as

TechnologyChromatography, AffinityDiagnostic Tests, RoutineEquipment DesignHIVHumansMaleProstate-Specific AntigenTime FactorsProstate-Specific Antigen

Identifiers

PMID24571349
PMCPMC3988681
OpenAlexW2083325111

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.